This page has only limited features, please log in for full access.

Ms. Chia-Wei Chang
Biomedical Platform and Incubation Service Division, Taiwan Instrument Research Institute, National Applied Research Laboratories, Hsinchu, Taiwan.

Basic Info

Basic Info is private.

Research Keywords & Expertise

0 MiRNA
0 Medical Device
0 Cellular and Molecular Biology
0 Cancer biology (initiation, progression, and metastases)
0 Cancer & Biomarkers

Honors and Awards

The user has no records in this section


Career Timeline

The user has no records in this section.


Short Biography

Assistant Engineer Biomedical Platform and Incubation Services Division National Applied Research Laboratories Taiwan Instrument Research Institute

Following
Followers
Co Authors
The list of users this user is following is empty.
Following: 0 users

Feed

Brief report
Published: 20 August 2021 in COVID
Reads 0
Downloads 0

Large-scale efforts have been persistently undertaken for medical prophylaxis and treatment of COVID-19 disasters worldwide. A variety of novel viral spike protein-targeted vaccines have been extensively distributed for global inoculation based on accelerated approval. With concerns of emerging spike protein mutations, we revisited the early but inconclusive clinical interest in the repurposed combination of azithromycin (AZT) and zinc supplements with safety advantages. The aim of this study is to provide in vitro proof of concept for IκBα associated rapid and synergistic suppression of angiotensin-converting enzymes 2 (ACE2) following combination treatments with AZT plus zinc sulfate in two human airway cells with ACE2 expression, Calu-3 and H322M, representative cells of the human upper and lower airway origin respectively. Clinical timing of AZT combined with zinc is indicated based on suppression of the key cellular entry molecule, ACE2, of SARS-CoV-2.

ACS Style

Chia-Wei Chang; Ming-Cheng Lee; Bor-Ru Lin; Yen-Pei Lu; Yih-Jen Hsu; Chun-Yu Chuang; Tsung-Tao Huang; Yin-Kai Chen. The Effect of Azithromycin Plus Zinc Sulfate on ACE2 Expression through IκBα of Human Respiratory Cells in SARS-CoV-2: In Vitro Study. COVID 2021, 1, 263 -275.

AMA Style

Chia-Wei Chang, Ming-Cheng Lee, Bor-Ru Lin, Yen-Pei Lu, Yih-Jen Hsu, Chun-Yu Chuang, Tsung-Tao Huang, Yin-Kai Chen. The Effect of Azithromycin Plus Zinc Sulfate on ACE2 Expression through IκBα of Human Respiratory Cells in SARS-CoV-2: In Vitro Study. COVID. 2021; 1 (1):263-275.

Chicago/Turabian Style

Chia-Wei Chang; Ming-Cheng Lee; Bor-Ru Lin; Yen-Pei Lu; Yih-Jen Hsu; Chun-Yu Chuang; Tsung-Tao Huang; Yin-Kai Chen. 2021. "The Effect of Azithromycin Plus Zinc Sulfate on ACE2 Expression through IκBα of Human Respiratory Cells in SARS-CoV-2: In Vitro Study." COVID 1, no. 1: 263-275.